OpenAlex Citation Counts

OpenAlex Citations Logo

OpenAlex is a bibliographic catalogue of scientific papers, authors and institutions accessible in open access mode, named after the Library of Alexandria. It's citation coverage is excellent and I hope you will find utility in this listing of citing articles!

If you click the article title, you'll navigate to the article, as listed in CrossRef. If you click the Open Access links, you'll navigate to the "best Open Access location". Clicking the citation count will open this listing for that article. Lastly at the bottom of the page, you'll find basic pagination options.

Requested Article:

The Influence of Cell Cycle Regulation on Chemotherapy
Ying Sun, Yang Liu, Xiaoli Ma, et al.
International Journal of Molecular Sciences (2021) Vol. 22, Iss. 13, pp. 6923-6923
Open Access | Times Cited: 187

Showing 1-25 of 187 citing articles:

The Role of Silver Nanoparticles in the Diagnosis and Treatment of Cancer: Are There Any Perspectives for the Future?
Peter Takáč, Radka Michalková, Martina Čižmáriková, et al.
Life (2023) Vol. 13, Iss. 2, pp. 466-466
Open Access | Times Cited: 73

Targeting the “hallmarks of aging” to slow aging and treat age-related disease: fact or fiction?
Maryam Keshavarz, Kan Xie, Kristina Schaaf, et al.
Molecular Psychiatry (2022) Vol. 28, Iss. 1, pp. 242-255
Open Access | Times Cited: 67

Cancer cell cycle heterogeneity as a critical determinant of therapeutic resistance
Ebrahim H. Maleki, Ahmad Reza Bahrami, Maryam Moghaddam Matin
Genes & Diseases (2023) Vol. 11, Iss. 1, pp. 189-204
Open Access | Times Cited: 46

Assessment of the electrostatic binding of ferrocenylmethyl-nitroaniline derivatives to DNA: A combined experimental and theoretical study
Touhami Lanez, Mehran Feizi‐Dehnayebi, Elhafnaoui Lanez
Journal of Molecular Structure (2024) Vol. 1308, pp. 138386-138386
Closed Access | Times Cited: 27

Advances in research on the anti-tumor mechanism of Astragalus polysaccharides
Qian Yang, Dandan Meng, Qinyuan Zhang, et al.
Frontiers in Oncology (2024) Vol. 14
Open Access | Times Cited: 13

Nanoparticle-Mediated Drug Delivery Systems for Precision Targeting in Oncology
Kamelia Hristova‐Panusheva, Charilaos Xenodochidis, Milena Georgieva, et al.
Pharmaceuticals (2024) Vol. 17, Iss. 6, pp. 677-677
Open Access | Times Cited: 12

Robust, anti-freezing and conductive bonding of chitosan-based double-network hydrogels for stable-performance flexible electronic
Yanyu Yang, Manhua Zhou, Junbo Peng, et al.
Carbohydrate Polymers (2021) Vol. 276, pp. 118753-118753
Closed Access | Times Cited: 56

Potential Prognostic Biomarkers of NIMA (Never in Mitosis, Gene A)-Related Kinase (NEK) Family Members in Breast Cancer
Gangga Anuraga, Wei‐Jan Wang, Nam Nhut Phan, et al.
Journal of Personalized Medicine (2021) Vol. 11, Iss. 11, pp. 1089-1089
Open Access | Times Cited: 56

Emerging nanotechnology-based therapeutics to combat multidrug-resistant cancer
Priya Yadav, Suresh V. Ambudkar, R. Nagarajan
Journal of Nanobiotechnology (2022) Vol. 20, Iss. 1
Open Access | Times Cited: 45

Mechanisms of action by sulphur compounds in Allium sativum. A review
Agatha Ngukuran Jikah, Great Iruoghene Edo
Pharmacological Research - Modern Chinese Medicine (2023) Vol. 9, pp. 100323-100323
Open Access | Times Cited: 26

A new class of anti-proliferative activity and apoptotic inducer with molecular docking studies for a novel of 1,3-dithiolo[4,5-b]quinoxaline derivatives hybrid with a sulfonamide moiety
Mostafa A. Ismail, Moustafa S. Abusaif, M. S. A. El‐Gaby, et al.
RSC Advances (2023) Vol. 13, Iss. 18, pp. 12589-12608
Open Access | Times Cited: 22

The bidirectional relationship between metabolism and cell cycle control
Frances F. Diehl, Kiera M. Sapp, Matthew G. Vander Heiden
Trends in Cell Biology (2023) Vol. 34, Iss. 2, pp. 136-149
Closed Access | Times Cited: 21

A Review of the Therapeutic Potential of Sulfur Compounds in Allium sativum
Agatha Ngukuran Jikah, Great Iruoghene Edo, Raghda Makia, et al.
Measurement Food (2024) Vol. 15, pp. 100195-100195
Open Access | Times Cited: 10

Luteolin as a potential therapeutic candidate for lung cancer: Emerging preclinical evidence
Jin Zhang, Yue Ma
Biomedicine & Pharmacotherapy (2024) Vol. 176, pp. 116909-116909
Open Access | Times Cited: 7

Nanomedicines: Emerging Platforms in Smart Chemotherapy Treatment—A Recent Review
Mosab Arafat, Molham Sakkal, Rami Beiram, et al.
Pharmaceuticals (2024) Vol. 17, Iss. 3, pp. 315-315
Open Access | Times Cited: 6

Exploiting Co(III)-Cyclopentadienyl Complexes To Develop Anticancer Agents
João Franco Machado, Sandra Cordeiro, Joana N. Duarte, et al.
Inorganic Chemistry (2024) Vol. 63, Iss. 13, pp. 5783-5804
Open Access | Times Cited: 6

The role of lncRNA NEAT1 in human cancer chemoresistance
Feng Long, Xue Li, Jingyu Pan, et al.
Cancer Cell International (2024) Vol. 24, Iss. 1
Open Access | Times Cited: 6

Pan-Cancer Analysis of KANK2: Clinical and Molecular Insights into Tumor Progression and Therapeutic Implications
Kai Zhao, Jie Lin, Yongzhi Li, et al.
Journal of Cancer (2025) Vol. 16, Iss. 4, pp. 1149-1166
Open Access

Developmental exposure to perfluorooctane sulfonate(PFOS) impairs the endometrial receptivity
Rui Ren, Xinyue Zhou, Tianyu Jia, et al.
Scientific Reports (2025) Vol. 15, Iss. 1
Open Access

Plant-derived compounds with antineoplastic activity: a literature review
Márlon de Castro Vasconcelos, Mayron Guedes Silva, Raphael Guedes Silva, et al.
Caderno Pedagógico (2025) Vol. 22, Iss. 1, pp. e13488-e13488
Closed Access

Undescribed diterpenes from Euphorbia mauritanica L. as modulators of the breast cancer resistance: Mechanistic and in silico studies
Ahmed F. Essa, Mai M. Elghonemy, Rehab F. Taher, et al.
Phytochemistry (2025), pp. 114418-114418
Closed Access

Page 1 - Next Page

Scroll to top